--- schema_version: "secwatch.filing_event.v1" accession: "0001157523-23-000880" form_type: "8-K" ticker: "CCRN" cik: "0001141103" company_name: "CROSS COUNTRY HEALTHCARE INC" filed_at: "2023-05-18T23:59:59+00:00" generated_at: "2026-06-14T20:49:21.730579+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.25 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Cross Country Healthcare annual meeting results: all directors elected, auditor ratified ## Summary - All eight director nominees elected; highest vote for Dwayne Allen at 29.2M, lowest for Gale Fitzgerald at 23.9M. - Ratification of Deloitte & Touche as auditor: 31.0M for, 239,556 against, 152,471 abstentions. - Advisory vote on executive compensation approved: 28.3M for, 473,260 against, 468,795 abstentions. - Non-binding advisory vote on frequency of say-on-pay: 1-year option received 27.3M votes, with 1.7M for 3-year. - All proposals passed with required majority; broker non-votes of 2,152,693 on director election and advisory votes. ## SEC filing metadata - accession: 0001157523-23-000880 - form_type: 8-K - ticker: CCRN - cik: 0001141103 - company_name: CROSS COUNTRY HEALTHCARE INC - filed_at: 2023-05-18T23:59:59+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.25 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/0001157523-23-000880-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/a53402539.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001157523-23-000880 - JSON: https://secwatch.observer/filing/0001157523-23-000880.json - Plain text: https://secwatch.observer/filing/0001157523-23-000880.txt ## Key facts - Shareholder Votes CROSS COUNTRY HEALTHCARE INC shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-16 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-05-16 source text: (ii) The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was approved as follows: For Against Abstentions Broker Non-Votes 30,971,030 239,556 152,471 0 evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/0001157523-23-000880-index.htm - Shareholder Votes CROSS COUNTRY HEALTHCARE INC shareholders voted on Advisory vote on frequency of future advisory votes on executive compensation at the 2023-05-16 meeting. - Proposal: say on pay frequency - Meeting: 2023-05-16 source text: (iv) The frequency periods for future non-binding stockholder advisory votes on the Company’s named executive officer compensation received the votes set forth below: 1 year 2 year 3 year Abstentions Broker Non-Votes 27,314,282 7,282 1,743,102 145,698 2,152,693 evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/0001157523-23-000880-index.htm - Shareholder Votes CROSS COUNTRY HEALTHCARE INC shareholders approved Advisory (non-binding) vote on compensation of named executive officers at the 2023-05-16 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-05-16 source text: (iii) The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the votes set forth below: For Against Abstentions Broker Non-Votes 28,268,309 473,260 468,795 2,152,693 evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/0001157523-23-000880-index.htm - Shareholder Votes CROSS COUNTRY HEALTHCARE INC shareholders approved Election of directors for a one-year term ending in 2024 or until their successors are duly elected and qualified at the 2023-05-16 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-05-16 source text: (i) A proposal to elect the directors listed below for a one-year term ending in 2024 or until their successors are duly elected and qualified was approved with the following vote: Director For Against Abstentions Broker Non-Votes Kevin C. Clark 28,128,854 1,069,398 12,112 2,152,693 Dwayne Allen 29,173,272 24,822 12,270 2,152,693 Venkat Bhamidipati 29,173,126 25,150 12,088 2,152,693 W. Larry Cash 27,669,744 1,528,548 12,072 2,152,693 Gale Fitzgerald 23,911,647 5,286,687 12,030 2,152,693 John A. Martins 28,596,103 602,048 12,213 2,152,693 Dr. Janice E. Nevin, MD, MPH 27,860,406 1,337,828 12,130 2,152,693 Mark Perlberg, JD 27,930,509 1,267,541 12,314 2,152,693 evidence_url: https://www.sec.gov/Archives/edgar/data/1141103/000115752323000880/0001157523-23-000880-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.